Fig. 4From: Dabrafenib for cutaneous melanoma infiltrating the vitreous: regression of metastasis and occurrence of uveitis as a secondary effectRetinographies performed after 16 weeks of dabrafenib treatment showing complete resolution of vitreous opacities in the right eyeBack to article page